{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:28:28Z","timestamp":1747153708462,"version":"3.40.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00228-020-02993-y","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T14:02:47Z","timestamp":1600092167000},"page":"189-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of a multifaceted intervention to promote the use of intravenous iron sucrose complex instead of ferric carboxymaltose in patients admitted for more than 24 h"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6573-8506","authenticated-orcid":false,"given":"Justine","family":"Touchard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Berdot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pouchot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Loustalot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"2993_CR1","unstructured":"Journal officiel de la R\u00e9publique fran\u00e7aise. Arr\u00eat\u00e9 du 6 avril 2011 relatif au management de la qualit\u00e9 de la prise en charge m\u00e9dicamenteuse et aux m\u00e9dicaments dans les \u00e9tablissements de sant\u00e9. https:\/\/www.legifrance.gouv.fr\/affichTexte.do?cidTexte=JORFTEXT000023865866&categorieLien=id. Accessed 31 Mar 2020"},{"key":"2993_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117383","volume":"10","author":"Z Tolkien","year":"2015","unstructured":"Tolkien Z, Stecher L, Mander AP, Pereira DIA, Powell JJ (2015) Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One 10:e0117383. https:\/\/doi.org\/10.1371\/journal.pone.0117383","journal-title":"PLoS One"},{"key":"2993_CR3","unstructured":"Bulletin officiel du minist\u00e8re des affaires sociales et de la sant\u00e9 (2014) Instruction DGOS du 24 janvier 2014 relative aux modalit\u00e9s d\u2019utilisation des sp\u00e9cialit\u00e9s \u00e0 base de fer injectable"},{"key":"2993_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40264-019-00868-5","volume":"43","author":"L Nathell","year":"2019","unstructured":"Nathell L, Gohlke A, Wohlfeil S (2019) Reported severe hypersensitivity reactions after intravenous iron administration in the European Economic Area (EEA) before and after implementation of risk minimization measures. Drug Saf 43:35\u201343. https:\/\/doi.org\/10.1007\/s40264-019-00868-5","journal-title":"Drug Saf"},{"key":"2993_CR5","first-page":"iii","volume":"8","author":"JM Grimshaw","year":"2004","unstructured":"Grimshaw JM, Thomas RE, MacLennan G et al (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess Winch Engl 8:iii\u2013iv 1\u201372","journal-title":"Health Technol Assess Winch Engl"},{"key":"2993_CR6","unstructured":"Journal officiel de la R\u00e9publique fran\u00e7aise. D\u00e9cret n\u00b0 2000-1316 du 26 d\u00e9cembre 2000 relatif aux pharmacies \u00e0 usage int\u00e9rieur et modifiant le code de la sant\u00e9 publique (deuxi\u00e8me partie : D\u00e9crets en Conseil d\u2019\u00c9tat). https:\/\/www.legifrance.gouv.fr\/affichTexte.do?cidTexte=JORFTEXT000000220429. Accessed 14 Oct 2019"},{"key":"2993_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1053\/j.gastro.2011.06.005","volume":"141","author":"R Evstatiev","year":"2011","unstructured":"Evstatiev R, Marteau P, Iqbal T et al (2011) FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 141:846\u2013853.e2. https:\/\/doi.org\/10.1053\/j.gastro.2011.06.005","journal-title":"Gastroenterology"},{"key":"2993_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cgh.2012.10.013","volume":"11","author":"R Evstatiev","year":"2013","unstructured":"Evstatiev R, Alexeeva O, Bokemeyer B, Chopey I, Felder M, Gudehus M, Iqbal T, Khalif I, Marteau P, Stein J, Gasche C (2013) Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 11:269\u2013277. https:\/\/doi.org\/10.1016\/j.cgh.2012.10.013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2993_CR9","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","volume":"103","author":"S Kulnigg","year":"2008","unstructured":"Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D'Haens G, Gasche C (2008) A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT\u00ae) randomized controlled trial. Am J Gastroenterol 103:1182\u20131192. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01744.x","journal-title":"Am J Gastroenterol"},{"key":"2993_CR10","doi-asserted-by":"publisher","unstructured":"Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O'Cathain A, Tinati T, Wight D, Baird J (2015) Process evaluation of complex interventions: Medical Research Council guidance. BMJ 350. https:\/\/doi.org\/10.1136\/bmj.h1258","DOI":"10.1136\/bmj.h1258"},{"key":"2993_CR11","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/jac\/dkg459","volume":"52","author":"F Ansari","year":"2003","unstructured":"Ansari F, Gray K, Nathwani D, Phillips G, Ogston S, Ramsay C, Davey P (2003) Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother 52:842\u2013848. https:\/\/doi.org\/10.1093\/jac\/dkg459","journal-title":"J Antimicrob Chemother"},{"key":"2993_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","volume":"27","author":"AK Wagner","year":"2002","unstructured":"Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002) Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27:299\u2013309","journal-title":"J Clin Pharm Ther"},{"key":"2993_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/qshc.2007.023887","volume":"18","author":"I Colombet","year":"2009","unstructured":"Colombet I, Sabatier B, Gillaizeau F, Prognon P, Begue D, Durieux P (2009) Long-term effects of a multifaceted intervention to encourage the choice of the oral route for proton pump inhibitors: an interrupted time-series analysis. Qual Saf Health Care 18:232\u2013235. https:\/\/doi.org\/10.1136\/qshc.2007.023887","journal-title":"Qual Saf Health Care"},{"key":"2993_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M (2011) Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Admin Pol Ment Health 38:65\u201376. https:\/\/doi.org\/10.1007\/s10488-010-0319-7","journal-title":"Admin Pol Ment Health"},{"key":"2993_CR15","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1136\/bmj.321.7274.1460","volume":"321","author":"C Ripouteau","year":"2000","unstructured":"Ripouteau C, Conort O, Lamas JP, Auleley GR, Hazebroucq G, Durieux P (2000) Effect of multifaceted intervention promoting early switch from intravenous to oral acetaminophen for postoperative pain: controlled, prospective, before and after study. BMJ 321:1460\u20131463. https:\/\/doi.org\/10.1136\/bmj.321.7274.1460","journal-title":"BMJ"},{"key":"2993_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13012-016-0447-x","volume":"11","author":"K Schipper","year":"2016","unstructured":"Schipper K, Bakker M, De Wit M et al (2016) Strategies for disseminating recommendations or guidelines to patients: a systematic review. Implement Sci 11:82. https:\/\/doi.org\/10.1186\/s13012-016-0447-x","journal-title":"Implement Sci"},{"key":"2993_CR17","unstructured":"Lawry R (2019) 3.2 What are implementation outcomes? In: Melb. Sch. Popul. Glob. Health. https:\/\/mspgh.unimelb.edu.au\/centres-institutes\/nossal-institute-for-global-health\/implementation-science\/how\/step-3-evaluating\/implementation-outcomes."},{"key":"2993_CR18","doi-asserted-by":"publisher","unstructured":"Jamtvedt G, Young JM, Kristoffersen DT et al (2006) Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev:CD000259. https:\/\/doi.org\/10.1002\/14651858.CD000259.pub2","DOI":"10.1002\/14651858.CD000259.pub2"},{"key":"2993_CR19","doi-asserted-by":"publisher","unstructured":"O\u2019Brien MA, Rogers S, Jamtvedt G et al (2007) Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev:CD000409. https:\/\/doi.org\/10.1002\/14651858.CD000409.pub2","DOI":"10.1002\/14651858.CD000409.pub2"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02993-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-02993-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02993-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T23:26:21Z","timestamp":1631575581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-02993-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2993"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-02993-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"17 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}